Learn More
Medchemexpress LLC 6-(4-chlorophenyl)-2,3-dihydro-N-[(1S)-2-hydroxy-1-methylethyl]-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-4 | 2242464-44-2 | MFCD32693912 | >98.0% | C18H18ClN5O3 | 10MG

Supplier: Medchemexpress LLC HY13582910MG
BAY 2416964 is a small-molecule aryl hydrocarbon receptor (AhR) antagonist developed as a clinical-stage oncology candidate. It inhibits AhR signaling in vitro, has shown cellular potency in reported assays, and has been evaluated in early-phase clinical studies as an immunomodulatory agent to enhance anti-tumor immune responses.
- Small-molecule aryl hydrocarbon receptor antagonist.
- Demonstrated cellular potency, reported IC50 ~341 nM.
- Investigated in early-phase clinical studies for solid tumors.
- High chemical purity typical for supplied samples (>98.0%).
- Suitable for preclinical pharmacology and mechanism-of-action studies.
- Molecular formula C18H18ClN5O3; molecular weight ~387.8.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.